Real-world applications in clinical documentation and trial matching
Q&A with new classical hematology program leader
Patient with TP53 mutation achieves full response with targeted therapy
Study also finds that 26% of children with cancer have mutations in DNA repair genes
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Concurrent treatment necessary for addressing progressive disease and infection
Psychosocial oncology offers a path forward
A conversation with Marcelo Pasquini, MD
Percutaneous stabilization can increase mobility without disrupting cancer treatment
International study supports change in clinical care in post-neoadjuvant setting
Early detection, prognostication and intervention may improve outcomes
Advertisement
Advertisement